Technical Articles

Tumor associated antigens (TAAs) are commonly used for diagnosis, but they also exist in normal tissues, limiting their therapeutic value. In contrast, neoantigens - peptides derived from tumor specific gene mutations - are only expressed in cancer cells. This unique property makes it an ideal target for eradicating tumors with minimal side effects.